Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

The FDA's big gamble on the new Alzheimer's drug

By C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
Share this article
The FDA approved Alzheimer's disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don't yet have.

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter